Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.
Determinants of the severity of comorbid migraine in multiple sclerosis.
B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.
Multiple sclerosis in Pakistan: histocompatibility antigen composition and disability.
The Ex Vivo Production of IL-6 and IL-21 by CD4(+) T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients.
Multiple sclerosis care in Latin America.
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
Crossfit training changes brain-derived neurotrophic factor and irisin levels at rest, after wingate and progressive tests, and improves aerobic capacity and body composition of young physically active men and women.
4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.
Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Internet-based social networking and its role in the evolution of chronic cerebrospinal venous insufficiency.
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Fenofibrate Inhibited the Differentiation of T Helper 17 Cells In Vitro.
Poster abstracts from the third international symposium on gait and balance in multiple sclerosis: selecting the right measures.
Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas.
The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.
[New therapies in multiple sclerosis].
B-cell enrichment and epstein-barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis.
Validation of a new quality of life scale related to multiple sclerosis and relapses.
Using Functional Electrical Stimulation Mediated by Iterative Learning Control and Robotics to Improve Arm Movement for People With Multiple Sclerosis.
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
Automatic white matter lesion segmentation using an adaptive outlier detection method.
Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content.
Pages
« first
‹ previous
…
245
246
247
248
249
250
251
252
253
…
next ›
last »